Provided by Tiger Trade Technology Pte. Ltd.

WAVE Life Sciences

3.78
-0.1000-2.58%
Post-market: 3.850.0700+1.85%19:40 EDT
Volume:3.75M
Turnover:14.31M
Market Cap:744.66M
PE:-3.51
High:3.96
Open:3.89
Low:3.77
Close:3.88
52wk High:21.73
52wk Low:3.56
Shares:197.00M
Float Shares:94.77M
Volume Ratio:0.94
T/O Rate:3.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0766
EPS(LYR):-1.2118
ROE:-67.42%
ROA:-33.60%
PB:1.64
PE(LYR):-3.12

Loading ...

WAVE Life Sciences Q2 EPS $(0.34) Misses $(0.31) Estimate, Sales $2.272M Miss $7.050M Estimate

Benzinga Earnings
·
Jul 30

Wave Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
Jul 30

WAVE Life Sciences Ltd Expected to Post a Loss of 31 Cents a Share - Earnings Preview

Reuters
·
Jul 28

Wave Life Sciences to Host Webcast, Call on Second-quarter Results

Reuters
·
Jul 23

Wave Life Sciences' Redomiciliation Scheme Set for Singapore Court Hearing

MT Newswires Live
·
Jul 08

Wave Life Sciences Sets July 14 Singapore Court Hearing for US Redomiciliation Scheme Approval

Reuters
·
Jul 08

Wave Life Sciences (WVE) Is Up 7.4% After Advancing RNA-Based Obesity Drug Into Phase 2a Trial

Simply Wall St.
·
Jul 05

Does Wave Life Sciences’ (WVE) RNA Obesity Program Signal a Shift in Its Competitive Positioning?

Simply Wall St.
·
Jun 27

Wave Life Sciences Holds Shareholder Meeting on Redomiciliation Scheme Proposal

Reuters
·
Jun 26

Wave Life Sciences initiates multidose portion of Inlight trial

TIPRANKS
·
Jun 24

Wave Life Sciences Initiates Phase 2a Inlight Trial of Wve-007 Obesity Drug Candidate

Reuters
·
Jun 24

Wave Life Sciences Announces Initiation of Phase 2a Portion of Inlight™ Trial of Wve-007 (inhbe Galnac-sirna) for Obesity and Cardiometabolic Diseases

THOMSON REUTERS
·
Jun 24

Wave Life Sciences - to Initiate Additional Phase 2 Trials of Wve-7 with Incretins in 2H 2026

THOMSON REUTERS
·
Jun 24

Wave Life Sciences (WVE) Stock Could Be 73% Undervalued After WVE 006 Data

Simply Wall St.
·
Jun 17

Mizuho Securities Remains a Buy on Wave Life Sciences (WVE)

TIPRANKS
·
Jun 13

Wave Life Sciences CEO to speak at Jefferies Global Healthcare Conference fireside chat

Reuters
·
Jun 01

Analysts Are Bullish on Top Healthcare Stocks: Wave Life Sciences (WVE), Boston Scientific (BSX)

TIPRANKS
·
May 28

Analysts Offer Insights on Healthcare Companies: Relay Therapeutics (RLAY) and Wave Life Sciences (WVE)

TIPRANKS
·
May 20

Wave Life Sciences' New Data From AATD Study Met Expectations, Wedbush Says

MT Newswires Live
·
May 19

Wave Life Sciences Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 19